GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000902 | Cell morphogenesis |
| Process | GO:0000904 | Cell morphogenesis involved in differentiation |
| Process | GO:0001525 | Angiogenesis |
| Process | GO:0001568 | Blood vessel development |
| Process | GO:0001655 | Urogenital system development |
| Process | GO:0001667 | Ameboidal-type cell migration |
| Process | GO:0001822 | Kidney development |
| Process | GO:0001944 | Vasculature development |
| Process | GO:0001945 | Lymph vessel development |
| Process | GO:0002009 | Morphogenesis of an epithelium |
| Process | GO:0002040 | Sprouting angiogenesis |
| Process | GO:0002042 | Cell migration involved in sprouting angiogenesis |
| Process | GO:0002090 | Regulation of receptor internalization |
| Process | GO:0002237 | Response to molecule of bacterial origin |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002682 | Regulation of immune system process |
| Process | GO:0002684 | Positive regulation of immune system process |
| Process | GO:0002694 | Regulation of leukocyte activation |
| Process | GO:0002696 | Positive regulation of leukocyte activation |
| Process | GO:0006935 | Chemotaxis |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007155 | Cell adhesion |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0007167 | Enzyme-linked receptor protein signaling pathway |
| Process | GO:0007169 | Transmembrane receptor protein tyrosine kinase signaling pathway |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007399 | Nervous system development |
| Process | GO:0007409 | Axonogenesis |
| Process | GO:0007411 | Axon guidance |
| Process | GO:0007416 | Synapse assembly |
| Process | GO:0008283 | Cell population proliferation |
| Process | GO:0008284 | Positive regulation of cell population proliferation |
| Process | GO:0008285 | Negative regulation of cell population proliferation |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009887 | Animal organ morphogenesis |
| Process | GO:0009888 | Tissue development |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010631 | Epithelial cell migration |
| Process | GO:0010837 | Regulation of keratinocyte proliferation |
| Process | GO:0010839 | Negative regulation of keratinocyte proliferation |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010942 | Positive regulation of cell death |
| Process | GO:0010975 | Regulation of neuron projection development |
| Process | GO:0010977 | Negative regulation of neuron projection development |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016477 | Cell migration |
| Process | GO:0022008 | Neurogenesis |
| Process | GO:0022407 | Regulation of cell-cell adhesion |
| Process | GO:0022409 | Positive regulation of cell-cell adhesion |
| Process | GO:0022603 | Regulation of anatomical structure morphogenesis |
| Process | GO:0022607 | Cellular component assembly |
| Process | GO:0023052 | Signaling |
| Process | GO:0030030 | Cell projection organization |
| Process | GO:0030100 | Regulation of endocytosis |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0030155 | Regulation of cell adhesion |
| Process | GO:0030182 | Neuron differentiation |
| Process | GO:0031175 | Neuron projection development |
| Process | GO:0031294 | Lymphocyte costimulation |
| Process | GO:0031295 | T cell costimulation |
| Process | GO:0031344 | Regulation of cell projection organization |
| Process | GO:0031345 | Negative regulation of cell projection organization |
| Process | GO:0032101 | Regulation of response to external stimulus |
| Process | GO:0032496 | Response to lipopolysaccharide |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032989 | Cellular component morphogenesis |
| Process | GO:0032990 | Cell part morphogenesis |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034329 | Cell junction assembly |
| Process | GO:0034330 | Cell junction organization |
| Process | GO:0034332 | Adherens junction organization |
| Process | GO:0035239 | Tube morphogenesis |
| Process | GO:0035295 | Tube development |
| Process | GO:0040011 | Locomotion |
| Process | GO:0040012 | Regulation of locomotion |
| Process | GO:0042127 | Regulation of cell population proliferation |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042330 | Taxis |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0043534 | Blood vessel endothelial cell migration |
| Process | GO:0043542 | Endothelial cell migration |
| Process | GO:0043616 | Keratinocyte proliferation |
| Process | GO:0044085 | Cellular component biogenesis |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0045216 | Cell-cell junction organization |
| Process | GO:0045595 | Regulation of cell differentiation |
| Process | GO:0045597 | Positive regulation of cell differentiation |
| Process | GO:0045785 | Positive regulation of cell adhesion |
| Process | GO:0048013 | Ephrin receptor signaling pathway |
| Process | GO:0048259 | Regulation of receptor-mediated endocytosis |
| Process | GO:0048468 | Cell development |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048514 | Blood vessel morphogenesis |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048646 | Anatomical structure formation involved in morphogenesis |
| Process | GO:0048666 | Neuron development |
| Process | GO:0048667 | Cell morphogenesis involved in neuron differentiation |
| Process | GO:0048699 | Generation of neurons |
| Process | GO:0048729 | Tissue morphogenesis |
| Process | GO:0048731 | System development |
| Process | GO:0048812 | Neuron projection morphogenesis |
| Process | GO:0048845 | Venous blood vessel morphogenesis |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048858 | Cell projection morphogenesis |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0048870 | Cell motility |
| Process | GO:0050673 | Epithelial cell proliferation |
| Process | GO:0050678 | Regulation of epithelial cell proliferation |
| Process | GO:0050680 | Negative regulation of epithelial cell proliferation |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050808 | Synapse organization |
| Process | GO:0050863 | Regulation of T cell activation |
| Process | GO:0050865 | Regulation of cell activation |
| Process | GO:0050867 | Positive regulation of cell activation |
| Process | GO:0050870 | Positive regulation of T cell activation |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0050920 | Regulation of chemotaxis |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051129 | Negative regulation of cellular component organization |
| Process | GO:0051147 | Regulation of muscle cell differentiation |
| Process | GO:0051149 | Positive regulation of muscle cell differentiation |
| Process | GO:0051153 | Regulation of striated muscle cell differentiation |
| Process | GO:0051155 | Positive regulation of striated muscle cell differentiation |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051249 | Regulation of lymphocyte activation |
| Process | GO:0051251 | Positive regulation of lymphocyte activation |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0060429 | Epithelium development |
| Process | GO:0060562 | Epithelial tube morphogenesis |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0060841 | Venous blood vessel development |
| Process | GO:0061564 | Axon development |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071216 | Cellular response to biotic stimulus |
| Process | GO:0071219 | Cellular response to molecule of bacterial origin |
| Process | GO:0071222 | Cellular response to lipopolysaccharide |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071396 | Cellular response to lipid |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0072001 | Renal system development |
| Process | GO:0072073 | Kidney epithelium development |
| Process | GO:0072176 | Nephric duct development |
| Process | GO:0072178 | Nephric duct morphogenesis |
| Process | GO:0072359 | Circulatory system development |
| Process | GO:0090130 | Tissue migration |
| Process | GO:0090132 | Epithelium migration |
| Process | GO:0097485 | Neuron projection guidance |
| Process | GO:0099054 | Presynapse assembly |
| Process | GO:0099072 | Regulation of postsynaptic membrane neurotransmitter receptor levels |
| Process | GO:0099149 | Regulation of postsynaptic neurotransmitter receptor internalization |
| Process | GO:0099172 | Presynapse organization |
| Process | GO:0120035 | Regulation of plasma membrane bounded cell projection organization |
| Process | GO:0120036 | Plasma membrane bounded cell projection organization |
| Process | GO:0120039 | Plasma membrane bounded cell projection morphogenesis |
| Process | GO:1901214 | Regulation of neuron death |
| Process | GO:1901216 | Positive regulation of neuron death |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901701 | Cellular response to oxygen-containing compound |
| Process | GO:1903037 | Regulation of leukocyte cell-cell adhesion |
| Process | GO:1903039 | Positive regulation of leukocyte cell-cell adhesion |
| Process | GO:1903847 | Regulation of aorta morphogenesis |
| Process | GO:1903849 | Positive regulation of aorta morphogenesis |
| Process | GO:1905207 | Regulation of cardiocyte differentiation |
| Process | GO:1905209 | Positive regulation of cardiocyte differentiation |
| Process | GO:1905651 | Regulation of artery morphogenesis |
| Process | GO:1905653 | Positive regulation of artery morphogenesis |
| Process | GO:2000725 | Regulation of cardiac muscle cell differentiation |
| Process | GO:2000727 | Positive regulation of cardiac muscle cell differentiation |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005887 | Integral component of plasma membrane |
| Component | GO:0014069 | Postsynaptic density |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0030054 | Cell junction |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031226 | Intrinsic component of plasma membrane |
| Component | GO:0032279 | Asymmetric synapse |
| Component | GO:0042734 | Presynaptic membrane |
| Component | GO:0043226 | Organelle |
| Component | GO:0045202 | Synapse |
| Component | GO:0045211 | Postsynaptic membrane |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097060 | Synaptic membrane |
| Component | GO:0098590 | Plasma membrane region |
| Component | GO:0098685 | Schaffer collateral - CA1 synapse |
| Component | GO:0098793 | Presynapse |
| Component | GO:0098794 | Postsynapse |
| Component | GO:0098839 | Postsynaptic density membrane |
| Component | GO:0098889 | Intrinsic component of presynaptic membrane |
| Component | GO:0098936 | Intrinsic component of postsynaptic membrane |
| Component | GO:0098948 | Intrinsic component of postsynaptic specialization membrane |
| Component | GO:0098978 | Glutamatergic synapse |
| Component | GO:0098984 | Neuron to neuron synapse |
| Component | GO:0099055 | Integral component of postsynaptic membrane |
| Component | GO:0099056 | Integral component of presynaptic membrane |
| Component | GO:0099060 | Integral component of postsynaptic specialization membrane |
| Component | GO:0099061 | Integral component of postsynaptic density membrane |
| Component | GO:0099146 | Intrinsic component of postsynaptic density membrane |
| Component | GO:0099240 | Intrinsic component of synaptic membrane |
| Component | GO:0099572 | Postsynaptic specialization |
| Component | GO:0099634 | Postsynaptic specialization membrane |
| Component | GO:0099699 | Integral component of synaptic membrane |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0046875 | Ephrin receptor binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1266738 | Developmental Biology |
| RCTM | RNO-2682334 | EPH-Ephrin signaling |
| RCTM | RNO-3928662 | EPHB-mediated forward signaling |
| RCTM | RNO-3928664 | Ephrin signaling |
| RCTM | RNO-3928665 | EPH-ephrin mediated repulsion of cells |
| RCTM | RNO-422475 | Axon guidance |
| RCTM | RNO-9675108 | Nervous system development |
| KEGG | rno04360 | Axon guidance |
Expression profile of Efnb2 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 7.0265102 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 6.962831 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 6.9958043 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 6.942988 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 6.771314 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 6.040288 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 6.784023 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 6.1481986 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 6.6987453 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 6.642436 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 7.0659904 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 6.6534133 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 6.89146 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 6.8364077 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 7.01078 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 6.797002 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 6.796658 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 6.6566005 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 6.710016 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 6.739541 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 7.28504 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 7.1011767 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 6.7508574 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 7.023482 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 4.897429234 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.112970091 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.010453494 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.081092203 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.264256413 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.455690853 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 13.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 13.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 19.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 9.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 17.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 23.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 22.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 57.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 28.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 24.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 18.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 30.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 19.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 37.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 24.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 32.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.285138 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.514128 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.645883 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.425138 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.976607 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.620185 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 6.632 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 7.401 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 7.668 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 3.923 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 5.093 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 10.1365 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 9.75477 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 6.78802 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 6.70863 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 9.83357 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 10.1261 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 9.89431 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 9.46131 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 8.38634 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 8.02465 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 5.55438 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 5.85094 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 9.03499 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 8.54105 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 9.05562 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 8.63558 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 182.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 209.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 227.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 252.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 247.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 168.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 190.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 219.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 196.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 243.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 203.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 203.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 197.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 293.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 264.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 150.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 225.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 231.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 181.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 186.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 193.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 255.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 231.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 215.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 209.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 152.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 246.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 259.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 274.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 232.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 214.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 232.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 247.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 212.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 218.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 154.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 5.899255 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 4.138427 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 5.99059 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 6.677054 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.654979 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.833491 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.681759 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.531699 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.472105 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.50942 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.510628 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.531286 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.841651 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.459559 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.769428 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.751388 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.608982 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.721107 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.710674 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.506484 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.682353 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.576377 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.802251 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.398024 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.699894 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.455821 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.748166 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.750127 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 85.5168 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 91.34084 |
